Changes to adrenaline autoinjector labels
Apr 19 2016:
In Australia, adrenaline is the approved name of the ingredient in autoinjector devices used for the emergency treatment of anaphylaxis. Currently, the only available autoinjector to treat anaphylaxis in Australia and New Zealand is supplied under the brand name EpiPen®. In some countries, including the USA, adrenaline is known as epinephrine.
During 2016 adrenaline autoinjector labels in Australia will start to show 'adrenaline (epinephrine)' as the ingredient name. Including both names on Australian medicines should help make it clear that these are the same ingredient, and reduce confusion for Australians travelling overseas, visitors to Australia and health professionals trained internationally.
ASCIA will gradually update all of its anaphylaxis resources over the next two years to also show 'adrenaline (epinephrine)' as communicated in the April 2016 issue of ASCIA News Update www.allergy.org.au/about-ascia/updates
ASCIA anaphylaxis resources include action plans and e-training courses. These are available open access from the ASCIA website:
For further information about changes to adrenaline labels visit www.tga.gov.au/changes-adrenaline-and-noradrenaline-labels
For information about the 1st National Allergy Strategy for Australia visit www.nationalallergystrategy.org.au
To donate to allergy and immunology research visit www.allergyimmunology.org.au